122 related articles for article (PubMed ID: 8258199)
21. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics, tissue distribution and excretion of vinflunine.
Zhao XP; Liu XQ; Wang YS; Wang H; Wang GJ
Eur J Drug Metab Pharmacokinet; 2006; 31(2):59-64. PubMed ID: 16898072
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of navelbine after oral administration in cancer patients.
Zhou XJ; Boré P; Monjanel S; Sahnoun Z; Favre R; Durand A; Rahmani R
Cancer Chemother Pharmacol; 1991; 29(1):66-70. PubMed ID: 1742851
[TBL] [Abstract][Full Text] [Related]
24. In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. II. Vinblastine and vincristine.
Zhou XJ; Martin M; Placidi M; Cano JP; Rahmani R
Eur J Drug Metab Pharmacokinet; 1990; 15(4):323-32. PubMed ID: 2088769
[TBL] [Abstract][Full Text] [Related]
25. Vinorelbine: a novel vinca alkaloid.
Toso C; Lindley C
Am J Health Syst Pharm; 1995 Jun; 52(12):1287-304; quizz 1340-1. PubMed ID: 7656116
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
Rowinsky EK; Noe DA; Trump DL; Winer EP; Lucas VS; Wargin WA; Hohneker JA; Lubejko B; Sartorius SE; Ettinger DS
J Clin Oncol; 1994 Sep; 12(9):1754-63. PubMed ID: 8083697
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, metabolism and biliary and urinary excretion of oral ramipril in man.
Verho M; Luck C; Stelter WJ; Rangoonwala B; Bender N
Curr Med Res Opin; 1995; 13(5):264-73. PubMed ID: 7555035
[TBL] [Abstract][Full Text] [Related]
28. Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.
Hong X; Yang ZY; Wang M; Lu L; Li YH; Hao X; Chen GY
Int J Mol Med; 2011 Dec; 28(6):953-60. PubMed ID: 21874222
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and biliary excretion of mitoxantrone in rats.
Yang X; Morris ME
J Pharm Sci; 2010 May; 99(5):2502-10. PubMed ID: 20013854
[TBL] [Abstract][Full Text] [Related]
30. Effect of vinorelbine on the growth of human myeloma cell lines in vitro.
Ochiai N; Shimazaki C; Inaba T; Fuchida S; Okano A; Hatsuse M; Hirai H; Ashihara E; Fujita N; Nakagawa M
Leuk Res; 2002 Aug; 26(8):731-8. PubMed ID: 12191568
[TBL] [Abstract][Full Text] [Related]
31. An animal model for the study of chronopharmacokinetics of drugs and application to methotrexate and vinorelbine.
Prémaud A; Rousseau A; Gicquel M; Ragot S; Manceau J; Laurentie M; Marquet P
Toxicol Appl Pharmacol; 2002 Sep; 183(3):189-97. PubMed ID: 12383710
[TBL] [Abstract][Full Text] [Related]
32. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
33. Biliary pharmacokinetic profile of piperacillin: experimental data and evaluation in man.
Brogard JM; Jehl F; Blickle JF; Dorner M; Arnaud JP; Monteil H
Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):462-70. PubMed ID: 2272706
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.
Rezai K; Urien S; Isambert N; Roche H; Dieras V; Berille J; Bonneterre J; Brain E; Lokiec F
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1529-36. PubMed ID: 21519841
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
Vincent J; Teng R; Dalvie DK; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
[TBL] [Abstract][Full Text] [Related]
36. Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer.
Jones S; Winer E; Vogel C; Laufman L; Hutchins L; O'Rourke M; Lembersky B; Budman D; Bigley J; Hohneker J
J Clin Oncol; 1995 Oct; 13(10):2567-74. PubMed ID: 7595708
[TBL] [Abstract][Full Text] [Related]
37. Biliary elimination of ticarcillin plus clavulanic acid (Claventin): experimental and clinical study.
Brogard JM; Jehl F; Blickle JF; Adloff M; Dorner M; Montell H
Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):135-44. PubMed ID: 2722309
[TBL] [Abstract][Full Text] [Related]
38. Preliminary results of biliary excretion of ramipril after T-drainage in cholecystectomy patients.
Luck C; Verho M; Umscheid T; Stelter WJ; Ziegler HP
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S116-21. PubMed ID: 1725018
[TBL] [Abstract][Full Text] [Related]
39. Experimental and clinical evaluation of the biliary pharmacokinetic profile of cefpiramide, a new cephalosporin with high hepatic elimination.
Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
Drugs Exp Clin Res; 1988; 14(8):519-27. PubMed ID: 3248507
[TBL] [Abstract][Full Text] [Related]
40. Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients.
Sabot C; Marquet P; Debord J; Carpentier N; Merle L; Lachâtre G
Eur J Clin Pharmacol; 1998 Apr; 54(2):171-5. PubMed ID: 9626924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
